NutritionGlobal Med Technologies(R) Licenses Transfusion Software Solution To Nationwide Healthcare System
Global Med Technologies(R), Inc. ("Global Med" or the "Company") (OTC Bulletin Board: GLOB), an international healthcare information technology company, announced that its Wyndgate Technologies(R) division has licensed its SafeTrace Tx(R) transfusion management software to a 40+ hospital healthcare system. The organization will also be contracting validation services, another cost-effective business solution, from Global Med"s PeopleMed subsidiary. Terms of the agreement were not disclosed.
SafeTrace Tx is transfusion management software which provides comprehensive tracking of orders, specimens, blood products, derivatives, and accessories with a complete testing and transfusion history in one consolidated record. These powerful features will assist the hospital healthcare system"s staff in selecting appropriate blood products for their patients and help to reduce waste and increase efficiency in their blood banks.
Thomas F. Marcinek, President and COO of Global Med Technologies, Inc., stated, "Large healthcare organizations, both domestically and internationally, are increasingly selecting Global Med companies as their vendor of choice. We believe this is a result of several positive factors: Global Med"s ability to meet the needs of our customers, our reputation, financial stability, and capacity to partner valued relationships with top laboratory and hospital information system vendors."
Mr. Marcinek continued, "We are pleased to have been chosen by this growing organization to implement our SafeTrace Tx transfusion management system in their hospitals. We appreciate their confidence in our ability to deliver quality business solutions and to develop a streamlined implementation plan."
About Global Med Technologies(R), Inc
Global Med Technologies, Inc. is an international healthcare information technology company which develops regulated and non-regulated products and services for the healthcare industry. As a leading provider of blood and laboratory systems and services, Global Med"s products are deployed in 20 countries and serve over 2,100 transfusion centers, blood banks and laboratory sites.
Global Med"s domestic companies are Wyndgate Technologies(R), a leader in software products and services for donor centers and hospital transfusion services; eDonor(R), which offers web-based donor relationship management systems; and PeopleMed(TM), Inc., which implements cost-effective software validation, consulting and compliance solutions to hospitals and donor centers.
Global Med"s European subsidiary, Inlog, SA, is a leading developer of donor center and transfusion management systems as well as cellular therapy software, laboratory information systems and quality assurance medical software systems internationally.
This news release may include statements that constitute forward-looking statements, usually containing the words "believe," "estimate," "project," "expects" or similar expressions. These statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements inherently involve risks and uncertainties that could cause actual results to differ materially from the forward-looking statements. By making these forward-looking statements, the Company undertakes no obligation to update these statements for revisions or changes after the date of this news release.
Global Med Technologies, Inc